INTRODUCTION: Glomus jugulare tumours (GJT) are benign tumours that arise locally and destructively in the base of the skull and can be successfully treated with radiotherapy. Patients have a long-life expectancy and the late effects of radiotherapy can be serious. Proton radiotherapy reduces doses to critical organs and can reduce late side effects of radiotherapy. The aim of this study was to report feasibility and early clinical results of 12 patients treated using proton therapy. METHODS: Between December 2013 and June 2019, 12 patients (pts) with GJT (median volume 20.4 cm3 ; range 8.5-41 cm3 ) were treated with intensity modulated proton therapy (IMPT). Median dose was 54 GyE (Gray Equivalents) (50-60 GyE) with daily fractions of 2 GyE. Twelve patients were analysed with a median follow-up time of 42.2 months (11.3-86.7). Feasibility, dosimetric parameters, acute and late toxicity and local effect on tumour were evaluated in this retrospective study. RESULTS: All patients finished treatment without interruption, with excellent dosimetric parameters and mild acute toxicity. Stabilisation of tumour size was detected on MRI in all patients. No changes in symptoms were observed in comparison with pre-treatment conditions. No late effects of radiotherapy were observed. CONCLUSION: Pencil-beam scanning proton radiotherapy is highly feasible in the treatment of large GJT with mild acute toxicity and promising short-term results. Longer follow-up and larger patient cohorts are required to further identify the role of pencil-beam scanning (PBS) for this indication.

Department of Health Care Disciplines and Population Protection Faculty of Biomedical Engineering Czech Technical University Prague Kladno Czech Republic

Department of Health Protection and Disaster Medicine Pavlov 1st Saint Petersburg State Medical University Saint Petersburg Russia

Department of Medical Biophysics and Informatics 3rd Faculty of Medicine Charles University Prague Prague Czech Republic

Department of Oncology 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Prague Czech Republic

Proton Therapy Centre Czech Prague Czech Republic

See more in PubMed

Ramina R, Maniglia JJ, Fernandes YB, et al. Jugular foramen tumors: diagnosis and treatment. Neurosurg Focus 2004; 17: E5. PubMed

Guss ZD, Batra S, Limb CJ, et al. Radiosurgery of glomus jugulare tumors: a meta‐analysis. Int J Radiat Oncol Biol Phys 2011; 81: e497–502. PubMed PMC

Wong BJ, Roos DE, Borg MF. Glomus jugulare tumours: a 15 year radiotherapy experience in South Australia. J Clin Neurosci 2014; 21: 456–61. PubMed

Toda K, Shibuya H, Hayashi K, Ayukawa F. Radiation‐induced cancer after radiotherapy for non‐Hodgkin's lymphoma of the head and neck: a retrospective study. Radiat Oncol 2009; 4: 21. PubMed PMC

Liscak R, Urgosik D, Chytka T, et al. Leksell gamma knife radiosurgery of the jugulotympanic glomus tumor: long‐term results. J Neurosurg 2014; 121: 198–202. PubMed

Bentzen SM, Constine LS, Deasy JO, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl): S3–9. PubMed PMC

https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009‐05‐29_QuickReference_8.5x11.pdf

Huy P, Kania T, Duet R, et al. Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases. Skull Base 2009; 19: 83–91. PubMed PMC

Gottfried ON, Liu JK, Couldwell WT, et al. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004; 17: E4. PubMed

Marangos N, Schumacher M. Facial palsy after glomus jugulare tumour embolization. J Laryngol Otol 1999; 113: 268–70. PubMed

Dupin C, Lang P, Dessard‐Diana B, et al. Treatment of head and neck paragangliomas with external beam radiation therapy. Int J Radiat Oncol Biol Phys 2014; 89: 353–9. PubMed

Ibrahim R, Ammori MB, Yianni J, et al. Gamma Knife radiosurgery for glomus jugulare tumors: a single‐center series of 75 cases. J Neurosurg 2017; 126: 1488–97. PubMed

Sallabanda K, Barrientos H, RDA I, et al. Long‐term outcomes after radiosurgery for glomus jugulare tumors. Tumori 2018; 104: 300–6. PubMed

Mariani‐Constantini R (ed). Paraganglioma: a multidisciplinary approach. Codon Publications, Brisbane, 2019. PubMed

Jansen TTG, Timmers HJLM, Marres HAM, et al. Results of a systematic literature review of treatment modalities for jugulotympanic paraganglioma, stratified per Fisch class. Clin Otolaryngol 2018; 43: 652–61. PubMed

Morgenstern PF, Shah K, Dunkel IJ, et al. Meningioma after radiotherapy for malignancy. J Clin Neurosci 2016; 30: 93–7. PubMed PMC

Huang R, Zhou Y, Hu S, et al. Radiotherapy exposure in cancer patients and subsequent risk of stroke: a systematic review and meta‐analysis. Front Neurol 2019; 10: 233. PubMed PMC

McDowell LJ, Ringash J, Xu W, et al. A cross sectional study in cognitive and neurobehavioral impairment in long‐term nasopharyngeal cancer survivors treated with intensity‐modulated radiotherapy. Radiother Oncol 2019; 131: 179–85. PubMed

McClelland S 3rd, Ciporen JN, Mitin T, et al. Long‐term stroke risk of single‐fraction photon‐based stereotactic radiosurgery for meningioma. Clin Neurol Neurosurg 2018; 173: 169–72. PubMed

Hasegawa H, Hanakita S, Shin M, et al. Re‐evaluation of the size limitation in single‐session stereotactic radiosurgery for brain arteriovenous malformations: detailed analyses on the outcomes with focusing on radiosurgical doses. Neurosurgery 2019; 86: 685–96. PubMed

Hankinson TC, Ogden AT, Canoll P, et al. Intraorbital and intracranial soft‐tissue glomus tumor in an 8‐year‐old child. Case report. J Neurosurg Pediatr 2008; 1: 389–91. PubMed